title: Dabigatran falsely elevates point of care international normalized ratio results.
authors.forename: Christina E
authors.initials: CE
authors.lastname: DeRemer
authors.forename: Jaspal S
authors.initials: JS
authors.lastname: Gujral
authors.forename: John W
authors.initials: JW
authors.lastname: Thornton
authors.forename: Robert A
authors.initials: RA
authors.lastname: Sorrentino
mesh_terms: D000368:Aged; D001562:Benzimidazoles / Q000009:adverse effects* / Q000627:therapeutic use; D000069604:Dabigatran; D005189:False Positive Reactions; D005260:Female; D006801:Humans; D019934:International Normalized Ratio; D008297:Male; D008875:Middle Aged; D010314:Partial Thromboplastin Time; D019095:Point-of-Care Systems; D013917:Thrombin / Q000037:antagonists & inhibitors*; D015091:beta-Alanine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D001562:Benzimidazoles; D015091:beta-Alanine; D013917:Thrombin; D000069604:Dabigatran